好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | C215 - Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies

Thursday 05/09/19
01:00 PM - 03:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Michelle L. Mauermann, MD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Participants should be able to identify the distinct forms of diabetic neuropathy; determine whether a neuropathy is likely to be related to diabetes; and obtain a rational, evidence-based approach to treating diabetic neuropathies. Participants should become familiar with the differential diagnosis and work-up of axonal neuropathies and use a rational, evidence-based approach to treat immune axonal neuropathies. Participants should become familiar with the relevance of monoclonal gammopathies in relationship to peripheral neuropathy; recognize the presentations of neurolymphoma; and get an update on new break-throughs in the field of ATTR amyloidosis.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Advanced Practice Provider
Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM EDT Introduction Introduction
Michelle L. Mauermann, MD, FAAN
01:05 PM - 01:40 PM EDT Speaker Update in Diabetic Neuropathies
Brian Callaghan, MD, MS, FAAN
01:40 PM - 02:15 PM EDT Speaker Update in Immune Axonal Neuropathies
Chafic Y. Karam, MD
02:15 PM - 02:50 PM EDT Speaker Update in Hematologic-related Neuropathies and hATTR Amyloidosis
Michelle L. Mauermann, MD, FAAN
02:50 PM - 03:00 PM EDT Q&A Discussion/Questions and Answers
Faculty Disclosures
Michelle L. Mauermann, MD, FAAN The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Brian Callaghan, MD, MS, FAAN Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from 好色先生. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIA. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Chafic Y. Karam, MD Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.